anti-Hepatitis C Virus, Helicase antibody product blog
Tags: Antibody; Monoclonal Antibody; Hepatitis C Virus, Helicase; anti-Hepatitis C Virus, Helicase antibody;
The Hepatitis C Virus, Helicase n/a (Catalog #MBS600666) is an Antibody produced from Mouse and is intended for research purposes only. The product is available for immediate purchase. MyBioSource\'s Hepatitis C Virus, Helicase can be used in a range of immunoassay formats including, but not limited to, ELISA (EL/EIA), Western Blot (WB).Suitable for use in ELISA and Western Blot.
Dilution: ELISA: 1:100,000
Western Blot: 1:16,000. Researchers should empirically determine the suitability of the Hepatitis C Virus, Helicase n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
The Hepatitis C Virus, Helicase n/a product has the following accession number(s) (GI #328948354) (NCBI Accession #YP_004365691.1). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
HCV Helicase is a nucleotide triphosphate-dependent enzyme that catalyzes the unwinding of positive-stranded RNA from hepatitis C virus.
Immunogen: Helicase antigen (50kD) from aa1193 - aa1657 of HCV 1a polyprotein. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing Hepatitis C Virus, Helicase are readily searchable from our website. Different antibodies against the same target such as Hepatitis C Virus, Helicase may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.